First FDA-cleared tool to assist clinicians in diagnosing and assessing autism in children as young as 16 months old ATLANTA – June 10, 2022 – EarliTec Diagnostics, Inc. (“EarliTec”), a digital health company developing novel diagnostic and therapeutic products for children with autism and early childhood vulnerabilities, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the EarliPoint™ … Continue reading EarliTec Diagnostics Receives FDA 510(k) Clearance for the EarliPoint Evaluation for Autism